Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Science News

Parkinson’s Foundation researchers and other scientists worldwide make continual advances in understanding Parkinson’s disease (PD) with revolutionary research. We monitor it all in our effort to improving care and advance research toward a cure. Browse our collection here:

Rosacea May Signal Increased Parkinson’s Risk
Monday, March 21, 2016

A new study finds that people with rosacea — persistently red, and sometimes bumpy, skin on the face — have nearly twice the risk of developing Parkinson’s disease (PD) compared to the general population. The study appears in the March 21 online edition of JAMA Neurology.

Early Weight Loss May Signal Faster Parkinson’s Progression
Friday, March 18, 2016

People with Parkinson’s disease (PD) who lost weight early on in the disease tended to experience a faster progression of motor symptoms over time compared to those whose weight held steady or who gained weight, according to the results of a study published in the January 11 online edition of JAMA Neurology.

FDA Approves Medtronic DBS Therapy for Early PD
Tuesday, March 8, 2016

The Parkinson’s Disease Foundation (PDF) alerts the community that Medtronic Deep Brain Stimulation (DBS) Therapy has been approved by the US Food and Drug Administration (FDA) for the treatment of Parkinson's disease (PD) in people with at least four years disease duration and with recent onset of motor complications, or motor complications of longer-standing duration that are not adequately controlled with medication.

Benefits and Challenges of Dental Implants for People with Parkinson’s
Monday, February 1, 2016

Are dental implants a better option than dentures for people with Parkinson’s disease (PD) who have lost teeth? A recent study finds that, although people with PD can benefit from dental implants, there are pitfalls too. Implants can break if a person clenches their jaw or grinds their teeth as part of PD movement symptoms and can be costly and time-consuming to maintain.

Potential New Drug Shows Promise for Neuroprotection
Monday, February 1, 2016

In tests on a mouse model of Parkinson’s disease (PD), an experimental drug in the early stages of development prevented damage to dopamine neurons by protecting them from inflammation. The results appear in the December 16 edition of the Journal of Neuroscience.

Potential New Therapy for Reducing Levodopa “Off-time”
Sunday, January 31, 2016

According to the results of a phase III clinical trial, a drug called opicapone may provide a new option for reducing "wearing-off" periods for people with Parkinson's disease (PD) who take levodopa. The researchers found that opicapone is modestly more effective than entacapone (Comtan®, also an ingredient in Stalevo®), the drug most commonly prescribed today for this purpose. It also offers the convenience of only one dose a day.

New Evidence Associates Elevated Urate with Lower Parkinson’s Risk
Wednesday, January 13, 2016

A new study found that healthy men, but not women, who had higher levels of urate in their blood, had a lower risk of developing Parkinson’s disease (PD). These results add to mounting evidence suggesting that urate may be protective against PD or may slow PD progression very early in the course of disease, before a person develops movement symptoms, in men.

Hepatitis C May Increase Parkinson’s Risk
Wednesday, December 23, 2015

A new study finds that being infected with the hepatitis C virus specifically, and not other types of hepatitis, may increase a person’s risk of developing Parkinson’s disease (PD). The results appear in the December 23 online edition of Neurology.

New Approach to Reducing Levodopa Side Effects
Monday, December 21, 2015

Scientists have identified a new drug strategy for reducing dyskinesias in Parkinson's disease (PD), while maintaining the beneficial effects of medications that contribute to their development. The research appears in the November 18 edition of Neuron.

Elastic Abdominal Binders May Prevent Dizziness on Standing
Monday, December 21, 2015

Wearing an elastic abdominal binder (a medical version of a girdle available in most drugstores) may help prevent low blood pressure on standing in people with Parkinson’s disease (PD), according to research published in the November 27 online edition of Movement Disorders Clinical Practice.


mail icon

Subscribe to get the latest news on treatments, research and other updates.